Reveal Biosciences announced a partnership agreement with Affymetrix that will enable Reveal to offer new RNA biomarker validation services. Reveal will use Affymetrix ViewRNA ISH products combined with their proprietary ImageDx software to provide RNA in situ hybridization (ISH) staining, imaging and quantification services. 

“We are thrilled to partner with Affymetrix to provide high-quality services using ViewRNA products. Our scientific expertise, combined with high-resolution imaging and our proprietary image analysis software, ImageDx™, form a powerful platform for the localization and quantification of mRNA in tissue samples,” said Dr. Claire Weston, CEO and founder of Reveal Biosciences. “This highly sensitive technology is changing the face of mRNA biomarker screening and analysis for translational research and diagnostics.”